Human inhalation pharmacokinetics of 1,1,2-trichloro-1,2,2-trifluoroethane (FC113)
Summary
Seven male volunteers were exposed to atmospheric concentrations of either 1980, 4100 or 7630mg m−3 1,1,2-trichloro-1,2,2-trifluoroethane (FC113) for 4 h. Blood and expired air samples were collected during the exposure period and for several days subsequently and analysed for FC113. Blood and breath concentrations of FC113 were related to the administered dose with some variation between individuals. The low blood/breath ratios measured are consistent with the low solubility of FC113 in blood. The absorption and elimination of FC113 can be described by a three-compartment model and the average half-lives of elimination of FC113 in breath were 0.22, 2.3 and 29 h. A pulmonary retention during the exposure period of 14% was measured but only 2.6 to 4.3% of the dose was recovered unchanged in breath after the exposure period, suggesting that FC113 could be metabolised following inhalation exposure. It is concluded that a practical method for biological monitoring during occupational exposure would be to measure end-tidal breath concentrations of FC113 in samples taken the morning after exposure. The predictive value of such a measurement can be improved if the results are normalised to the body fat content of individual workers which can be estimated from height and weight measurements.
Key words
Experimental human exposure Chlorofluorocarbons Pharmacokinetics Biological monitoring 1,1,2-Trichloro-1,2,2-trifluoroethanePreview
Unable to display preview. Download preview PDF.
References
- Angerer J, Schroder B, Heinrich R (1985) Exposure to fluorotrichloromethane (R-11). Int Arch Occup Environ Health 56:67–72PubMedCrossRefGoogle Scholar
- Astrand I (1983) Effect of physical exercise on uptake distribution and elimination of vapours in man. In: Fiserova-Bergerova V (ed) Modelling of inhalation exposure to vapours: uptake, distribution and elimination, vol. II. CRC Press, Boca Raton, Florida, p 109Google Scholar
- Christofano EE, Bryant JB, Trowell JM (1969) Human exposures to 1,1,2-trichloro-1,2,2-trifluoroethane. Am Ind Hyg Assoc Conf May 10-16. Denver, Colorado. Am Ind Hyg Assoc J 30:p 134 [Abstr 91]Google Scholar
- DHSS/MRC (1976) Report on research on obesity. Compiled by W. P. J. James, London, HMSOGoogle Scholar
- EPA (1983) Health assessment document for 1,1,2-trichlorol,2,2-trifluoroethane (Chlorofluorocarbon FC113) January 1983 (Report No. EPA-600/8-82-002)Google Scholar
- Fiserova-Bergerova V (1983) Modelling of metabolism and excretion in vivo. In: Fiserova-Bergerova V (ed) Modelling of inhalation exposure to vapors: uptake, distribution and elimination, vol. 1. CRC Press, Boca Raton, Florida, p 110Google Scholar
- Gibaldi M, Perrier D (1982) Pharmacokinetics, 2nd ed. Marcel Dekker, New YorkGoogle Scholar
- Guberan E, Fernandez J (1974) Control of exposure to tetra-chloroethylene by measuring alveolar concentrations: theoretical approach using a mathematical model. Br J Ind Med 31:159–167PubMedGoogle Scholar
- Health and Safety Executive (1987) Occupational exposure limits. Guidance Note EH40/87. HMSO LondonGoogle Scholar
- Mergner GW, Blake DA, Helrich M (1975) Biotransformation and elimination of 14C-trichlorofluoromethane (FC11) and 14C-dichlorodifluoromethane (FC12) in man. Anaesthesiology 42:345–351CrossRefGoogle Scholar
- Piotrowski J (1971) The application of metabolic and excretion kinetics to problems of industrial toxicology. US Government Printing Office, Washington DC, p 107Google Scholar
- Reinhardt CF, McLaughlin ME, Maxfield ME, Mullin LS, Smith PE (1971) Human exposures to fluorocarbon 113. Am Ind Hyg Assoc J 32:143–152PubMedGoogle Scholar
- Sato A, Nakajima T (1979) Partition coefficients of some aromatic hydrocarbons and ketones in water, blood and oil. Br J Ind Med 36:231–234PubMedGoogle Scholar
- Savolainen H, Pfaffli P (1980) Dose dependent neurochemical effects of 1,1,2-trichloro-1,2,2-trifluoroethane inhalation exposure in rats. Toxicol Lett 6:43–49PubMedCrossRefGoogle Scholar
- Shea SA, Walter J, Murphy K, Guz A (1987) Evidence for individuality of breathing patterns in resting healthy man. Resp Physiol 68:331–334CrossRefGoogle Scholar
- Triebig G, Burkhardt K (1978) Occupational medicine investigations into occupational exposure to FC113. Int Arch Occup Environ Health 42:129–135PubMedCrossRefGoogle Scholar
- Trochimowicz HJ, Azar A, Terrill JB, Mullin LS (1974) Blood levels of fluorocarbon related to cardiac sensitisation Part II. Am Ind Hyg Assoc J 35:632–639PubMedGoogle Scholar
- Vainio H, Nickels J, Heinonen T (1980) Dose related hepatotoxicity of 1,1,2-trichloro-1,2,2-trifluoroethane in short term intermittent inhalation exposure in rats. Toxicology 18:17–25PubMedCrossRefGoogle Scholar
- Veulemans H, Masschelein R (1978) Experimental human exposure to toluene. II. Toluene in venous blood during and after exposure. Int Arch Occup Environ Health 42:105–117PubMedCrossRefGoogle Scholar
- Wilson HK, Ottley TW (1981) The use of a transportable mass spectrometer for the direct measurement of industrial solvents in breath. Biomed Mass Spec 8:606–610CrossRefGoogle Scholar
- Wilson HK, Robertson SM, Waldron HA, Gompertz D (1983) Effect of alcohol on the kinetics of mandelic acid excretion in volunteers exposed to styrene vapour. Br J Ind Med 40:75–80PubMedGoogle Scholar